IC Logo
Header Image Header Image Header Image
Inventive Capital > Advisory Board
5 September, 2010

Advisory Board

Bio Name Position
Bio Mr. Montague W. Style, OBE Advisory Board Member
Bio Mr. Andrew Boyle Advisory Board Member
Bio Mr. Roger Balsiger Advisory Board Member
Bio Dr. Jost Harr Advisory Board Member
Bio Dr. Max Brauchli Advisory Board Member
Bio Mr. Travis Seegmiller Advisory Board Member
Bio Mr. Lars-Johan Cederbrant Advisory Board Member
Bio Mr. Benedict Gummer Advisory Board Member


Montague W. Style, OBE: Non-Executive Chairman
  • Appointed Officer of the Order of the British Empire for service to British business interests in Switzerland
  • Former senior executive at Novartis and CIBA-GEIGY where he had P&L responsibility for businesses in Europe, Asia-Pacific, Middle East and Latin America
  • Former President of the British-Swiss Chamber of Commerce
  • Founding partner of Quilt Solutions Ltd., a strategic partnering consultancy for the life sciences sector
  • Business Development Advisor at AmVac AG
  • Executive coach at I.J. Martin & Cie.
Andrew Boyle: Advisory Board Member
  • Co-founder and director of London Capital Finance Limited, which provides capital markets services to smaller companies and private investors
  • Chairman of Apollo VCT, a venture capital trust managed by Octopus Investments
  • A former managing director of the Fixed Income Division of Citigroup Global Markets Limited
  • A former board member of J. Henry Schroder & Co. Limited
Mr. Roger Balsiger: Advisory Board Member
  • Hon. Chairman MOSER GROUP AG, Swiss luxury watch-making company
  • Fmr. Senior manager Credit Suisse Group/Winterthur Life and Pensions
  • Fmr. Exec. board Credit Suisse/Winterthur-Columna
  • Fmr. Senior executive at Zurich Financial Services
Dr. Jost Harr: Advisory Board Member
Dr. Max Brauchli: Advisory Board Member
  • Board member of Bio Medinvest AG, a venture capital firm that focuses on healthcare investments in the Alpine Rim
  • Former Head of Corporate Business Development and Mergers & Acquisitions at Roche
  • Former Vice-Chairman of ICN International, Inc., a pharmaceutical company with over 8,000 employees in Southern Europe
  • Co-founder and former Director of Novuspharma S.p.A
  • Co-founder and former Director of NMT, a venture capital fund formed with Roche, which later merged with HBM Bioventures
  • Chairman of the Board of Directors of Pharma Sens, a bio-medtech start-up company
Travis Seegmiller: Advisory Board Member
  • Associate at Patton Boggs LLP, a top Washington based law firm that specialises in industrial advocacy with the United States government
  • Advisor to Senator John Breaux, former Chief Deputy Whip in the United States Senate
  • Advisor to the Andean Parliament regarding the formation of the South American Union
  • Policy Advisor for The Forum on Democracy and Trade in Washington DC
  • Former management consultant with McKinsey & Co.
Lars-Johan Cederbrant: Advisory Board Member
  • CFO of Artimplant, a publically listed, Swedish biomaterials company
  • Former CEO and Acting CFO at CardioBridge GmbH, a Swiss medical technology company
  • Acting CFO of JOMED Group, a public medical technology company, during its restructuring and merger with Abbott Vascular
  • Former Management Consultant with Andersen Business Consulting, specialising in Strategy, Finance, and Economics
Tony Fish: Advisory Board Member
  • Chairman and founder of AMF Ventures, a London based investor and advisor in the wireless technology space
  • Non-Executive Director at 2Ergo, Chronos Technology, Probability PLC and SAS Group
  • Former Head of Wireless Investment at Antfactory
  • Project Director of M&A at BT PLC
  • Author of MobileWeb 2.0, a new book about the mobile internet market
Benedict Gummer: Advisory Board Member
  • Operations Director at Sancroft, a London based consultancy focused on corporate responsibility issues
  • Experience advising multinational corporations on environmental, human rights and corruption issues
  • Special expertise in biofuels and and other emerging alternative energy technologies
Inventive Capital
3rd Floor Kingsbury House, 15-17 King Street
London SW1Y 6QU, United Kingdom
Telephone:
+44 (0) 207 100 4325

Fax:
+44 (0) 207 900 6016

Email:
info@inventivecapital.com